Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference-Reference-Cited by-同舟云学术

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

Published:2023-11 Issue:5 Volume:79 Page:1254-1269
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ghany Marc G.,Buti Maria,Lampertico Pietro,Lee Hannah M.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Hepatology

Reference72 articles.

1. Guidance for design and endpoints of clinical trials in chronic hepatitis B-report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference;Cornberg;J Hepatol,2020

2. Hepatitis B cure: from discovery to regulatory approval;Lok;Hepatology,2017

3. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues;Yip;J Hepatol,2019

4. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss;Yip;J Hepatol,2023

5. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B;Hsu;Hepatology,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients;Antiviral Research;2024-11

2. Is HBV RNA a new endpoint of HBV cure?;Saudi Journal of Gastroenterology;2024-09

3. Virological markers for clinical trials in chronic viral hepatitis;JHEP Reports;2024-09

4. JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2;Journal of Hepatology;2024-09

5. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy;Biomarker Research;2024-08-15